The Myelin Disorders Biorepository Project:
The Myelin Disorders Biorepository Project (MDBP) seeks to collect and analyze clinical data and biological samples from leukodystrophy patients worldwide to support ongoing and future research projects.
Interventional (Clinical Trial)
A Phase 2 Safety, Tolerability, and Proof-of-Concept Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented Glia (ALSP)
For more details on the Vigil Neuroscience VGL101 clinical trial visit the Ignite website: Ignite Study - ALSP Study.